Deferasirox (Exjade)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Deferasirox (Exjade), covering 2016-11-17 to 2016-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload [Phase 4]